about genphar...
mission statement
GenPhar’s mission is to become a leading provider of biodefense, prophylactic and therapeutic vaccines for the world’s most dangerous viral diseases.
To reach its goals, GenPhar will leverage the advantage of its proven safe and effective ProVax and TheraVax vaccine platforms - unique technologies capable of producing multiple vaccine products.
company history
GenPhar was founded in 1999 by a group of entrepreneurs from New York and experts in the fields of microbiology and immunology. The company was founded on cutting-edge technology and remains dedicated to the diagnosis, prevention and treatment of infectious diseases.


print this page
site map